SYSTON PHARMA LIMITED

15763334
Active London

Activities of venture and development capital companies

0 employees website.com
Activities of venture and development capital companies
S

SYSTON PHARMA LIMITED

15763334

Activities of venture and development capital companies

Founded 5 Jun 2024 Active London, United Kingdom 0 employees website.com
Activities of venture and development capital companies
Accounts Submitted 3 Nov 2025 Next due 31 Oct 2026 4 months remaining
Confirmation Submitted 9 Jun 2025 Next due 18 Jun 2026 1 day overdue
Net assets £108K
Total assets £131K
Total Liabilities £23K
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Mercer & Hole Llp 3 Lombard Street London EC3V 9AA United Kingdom

Full company profile for SYSTON PHARMA LIMITED (15763334), an active company based in London, United Kingdom. Incorporated 5 Jun 2024. Activities of venture and development capital companies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Feb → 31 Jan 2025
Type total-exemption-full
Next accounts 31 Jan 2026
Due by 31 Oct 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2024–2024)

Cash in Bank

£111.51k

Net Assets

£108.11k

Total Liabilities

£22.59k

Turnover

N/A

Employees

N/A

Debt Ratio

17%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Jan Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active
Status
Charles Waite MorganDirectorBritish,australianUnited Kingdom675 Jun 2024Active

Shareholders

Shareholders (1)

Charles Morgan
100.0%
1

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Charles Waite Morgan

British,australian

Active
Notified 5 Jun 2024
Residence United Kingdom
DOB May 1959
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 May 2026AddressChange Registered Office Address Company With Date Old Address New Address
3 Nov 2025AccountsAnnual accounts made up to 31 Jan 2025
9 Jun 2025Confirmation StatementConfirmation statement made on 4 Jun 2025 with updates
9 Jun 2025Persons With Significant ControlChange to Mr Charles Waite Morgan as a person with significant control on 9 Jun 2025
9 Jun 2025OfficersChange to director Mr Charles Waite Morgan on 9 Jun 2025
22 May 2026 Address

Change Registered Office Address Company With Date Old Address New Address

3 Nov 2025 Accounts

Annual accounts made up to 31 Jan 2025

9 Jun 2025 Confirmation Statement

Confirmation statement made on 4 Jun 2025 with updates

9 Jun 2025 Persons With Significant Control

Change to Mr Charles Waite Morgan as a person with significant control on 9 Jun 2025

9 Jun 2025 Officers

Change to director Mr Charles Waite Morgan on 9 Jun 2025

Recent Activity

Latest Activity

Change Registered Office Address Company With Date Old Address New Address

3 weeks ago on 22 May 2026

Annual accounts made up to 31 Jan 2025

7 months ago on 3 Nov 2025

Confirmation statement made on 4 Jun 2025 with updates

1 years ago on 9 Jun 2025

Change to Mr Charles Waite Morgan as a person with significant control on 9 Jun 2025

1 years ago on 9 Jun 2025

Change to director Mr Charles Waite Morgan on 9 Jun 2025

1 years ago on 9 Jun 2025